Biotech

All Articles

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Biography has been a biotech trying to find a pipeline after it ditched its own lead possess...

Biogen ignores Denali Alzheimer's collab

.Biogen has returned rights to a very early Alzheimer's illness course to Denali Rehabs, leaving a l...

Takeda faucets new head of US oncology business-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings...

Vertex, hammered by AATD again, falls 2 assets on dispose of heap

.Vertex's try to treat an unusual hereditary illness has hit another misfortune. The biotech shook t...

Vir increases 3 T-cell engagers coming from Sanofi, gives up 25% of personnel

.Vir Biotechnology's second-quarter profits record wasn't except significant information. The provid...

Galapagos stops briefly CAR-T cell therapy trial over Parkinsonism case

.Galapagos has actually paused application in a test of a BCMA-directed CAR-T tissue treatment, pump...

James Wilson leaving behind Penn to introduce 2 new biotechs

.After much more than 30 years, genetics treatment pioneer James Wilson M.D., Ph.D., is leaving the ...

3 biotechs try to beat the summer warm through dropping workers

.As biotechs seek to transform a new page in August, at least three firms have dropped personnel in ...

venBio elevates $528M for fifth life sciences VC fund

.Veteran financial backing firm venBio has lifted an additional half a billion bucks to acquire biot...

Otsuka pays out $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Pharmaceutical has gotten Boston-based Jnana Rehabs for $800 million so the Eastern biotech ...